Puma Biotechnology Stock
PBYI Stock: Setting up to Stage an Advance Puma Biotechnology Inc (NYSE:PBYI) stock staged quite an advance in May 2017 as investors' concerns about poor earnings results were cast away after some positive news. The U.S. Food and Drug Administration (FDA) approved the company's "Neratinib" drug for the treatment of…
